V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024460 | 20010394 | 1.68 | 76.6 | Adjuvant (A) | 2013-04-14 | 2013-04-28 | FEC + DOCETAXEL | N | N | 20086435 | FEC + DOCETAXEL |
| 20024461 | 20010394 | 1.67 | 63 | Neo-adjuvant (N) | 2015-05-21 | 2015-05-24 | FEC 100 + DOCETAXEL | 2 | N | 20086435 | FEC + DOCETAXEL |
| 20024462 | 20010394 | null | 56.3 | Adjuvant (A) | 2014-10-21 | 2014-10-28 | FEC + DOCETAXEL | N | null | 20086435 | FEC + DOCETAXEL |
| 20024463 | 20010395 | 1.59 | 109.3 | Adjuvant (A) | 2014-06-15 | 2014-06-17 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20086450 | FEC + DOCETAXEL |
| 20024464 | 20010396 | 1.51 | 71.9 | Not known (9) | null | 2016-05-20 | FEC + DOCETAXEL | N | null | 20086451 | FEC + DOCETAXEL |
| 20024465 | 20010396 | 1.71 | null | Adjuvant (A) | 2016-12-25 | 2017-01-05 | FEC + DOCETAXEL | 99 | N | 20086451 | FEC + DOCETAXEL |
| 20024466 | 20010397 | 1.69 | 77.5 | Adjuvant (A) | 2015-02-24 | 2015-03-08 | FEC 100 + DOCETAXEL | 2 | N | 20086457 | FEC + DOCETAXEL |
| 20024467 | 20010397 | 1.58 | 143.2 | Curative (C) | 2014-05-02 | 2014-05-05 | FEC + DOCETAXEL | 02 | N | 20086457 | FEC + DOCETAXEL |
| 20024468 | 20010397 | null | null | Adjuvant (A) | 2013-04-23 | 2013-05-10 | FEC 100 + DOCETAXEL | N | null | 20086457 | FEC + DOCETAXEL |
| 20024469 | 20010398 | null | null | Adjuvant (A) | 2014-05-14 | 2014-06-11 | FEC 100 + DOCETAXEL | Y | N | 20086469 | FEC + DOCETAXEL |
| 20024470 | 20010398 | 1.64 | 97.6 | Adjuvant (A) | 2014-03-10 | 2014-03-11 | FEC + DOCETAXEL | 02 | N | 20086469 | FEC + DOCETAXEL |
| 20024471 | 20010399 | 1.64 | 59.5 | Neo-adjuvant (N) | 2013-07-02 | 2013-08-08 | FEC + DOCETAXEL | N | N | 20086472 | FEC + DOCETAXEL |
| 20024472 | 20071024 | null | null | Adjuvant (A) | 2013-05-29 | 2013-06-11 | FEC 100 + DOCETAXEL | N | null | 20086474 | FEC + DOCETAXEL |
| 20024473 | 20071024 | 1.6 | 63.7 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-01 | FEC 100 + DOCETAXEL | N | N | 20086474 | FEC + DOCETAXEL |
| 20024474 | 20010400 | 1.69 | 76.6 | Adjuvant (A) | 2013-12-29 | 2014-01-27 | FEC 100 + DOCETAXEL | N | N | 20086486 | FEC + DOCETAXEL |
| 20024475 | 20010400 | null | 63 | Adjuvant (A) | 2016-01-04 | 2016-01-09 | FEC 100 + DOCETAXEL | N | null | 20086486 | FEC + DOCETAXEL |
| 20024476 | 20010401 | 1.81 | 96 | Neo-adjuvant (N) | 2015-07-07 | 2015-07-21 | FEC 100 + DOCETAXEL | 2 | N | 20086491 | FEC + DOCETAXEL |
| 20024477 | 20010402 | 1.51 | 86 | Adjuvant (A) | 2015-09-26 | 2015-09-27 | FEC + DOCETAXEL | 2 | N | 20086492 | FEC + DOCETAXEL |
| 20024478 | 20010403 | 1.63 | 85 | Adjuvant (A) | 2014-10-30 | 2014-11-14 | FEC + DOCETAXEL | 2 | null | 20086493 | FEC + DOCETAXEL |
| 20024479 | 20010404 | 1.6 | 82.15 | Adjuvant (A) | 2017-01-21 | 2017-01-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20086495 | FEC + DOCETAXEL |
| 20024480 | 20010404 | 1.67 | 74.8 | Adjuvant (A) | 2014-05-06 | 2014-05-07 | FEC + DOCETAXEL | 02 | N | 20086495 | FEC + DOCETAXEL |
| 20024481 | 20010404 | 1.65 | 97.3 | Adjuvant (A) | 2014-04-16 | 2014-04-22 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | Y | 20086495 | FEC + DOCETAXEL |
| 20024482 | 20010404 | 1.61 | null | Adjuvant (A) | 2014-06-01 | 2014-06-09 | FEC + DOCETAXEL | N | N | 20086495 | FEC + DOCETAXEL |
| 20024483 | 20010404 | null | 78.7 | Adjuvant (A) | 2015-01-16 | 2015-01-23 | FEC + DOCETAXEL | N | N | 20086495 | FEC + DOCETAXEL |
| 20024484 | 20010405 | 1.72 | null | null | 2013-08-02 | 2013-08-05 | FEC + DOCETAXEL | N | null | 20086508 | FEC + DOCETAXEL |
| 20024485 | 20010406 | null | null | Neo-adjuvant (N) | 2013-12-03 | 2013-12-25 | FEC 100 + DOCETAXEL | N | N | 20086513 | FEC + DOCETAXEL |
| 20024486 | 20071027 | 1.69 | 63 | Adjuvant (A) | 2015-07-17 | 2015-07-18 | FEC + DOCETAXEL | 02 | N | 20086514 | FEC + DOCETAXEL |
| 20024487 | 20010407 | 1.64 | 80.8 | Adjuvant (A) | 2015-01-28 | 2015-02-10 | FEC + DOCETAXEL | 2 | N | 20086516 | FEC + DOCETAXEL |
| 20024488 | 20071028 | null | 73.75 | Neo-adjuvant (N) | null | 2013-05-27 | FEC + DOCETAXEL | null | null | 20086517 | FEC + DOCETAXEL |
| 20024489 | 20010408 | null | 61.8 | Adjuvant (A) | 2014-07-24 | 2014-08-06 | FEC + DOCETAXEL | 02 | N | 20086524 | FEC + DOCETAXEL |
| 20024490 | 20010408 | 1.55 | 57.7 | Neo-adjuvant (N) | 2015-11-24 | 2015-12-03 | FEC + DOCETAXEL | 02 | N | 20086524 | FEC + DOCETAXEL |
| 20024491 | 20010409 | 1.66 | 87 | Neo-adjuvant (N) | null | 2017-07-28 | FEC + DOCETAXEL | N | N | 20086529 | FEC + DOCETAXEL |
| 20024492 | 20010409 | 1.74 | 69.4 | Adjuvant (A) | 2015-12-24 | 2015-12-29 | FEC 100 + DOCETAXEL | 2 | N | 20086529 | FEC + DOCETAXEL |
| 20024493 | 20010409 | null | 43.3 | Adjuvant (A) | 2014-06-26 | 2014-06-26 | FEC + DOCETAXEL | 02 | N | 20086529 | FEC + DOCETAXEL |
| 20024494 | 20010409 | 1.75 | 77.8 | Adjuvant (A) | 2015-09-26 | 2015-10-02 | FEC + DOCETAXEL | 02 | N | 20086529 | FEC + DOCETAXEL |
| 20024495 | 20010410 | 1.67 | 69 | Neo-adjuvant (N) | 2015-07-19 | 2015-07-19 | FEC + DOCETAXEL | 02 | N | 20086553 | FEC + DOCETAXEL |
| 20024496 | 20010411 | 1.59 | 120 | Adjuvant (A) | 2014-12-15 | 2014-12-15 | FEC 100 + DOCETAXEL | 2 | N | 20086557 | FEC + DOCETAXEL |
| 20024497 | 20010411 | 1.65 | 66.4 | Adjuvant (A) | 2017-05-24 | 2017-05-30 | FEC 100 + DOCETAXEL | 2 | N | 20086557 | FEC + DOCETAXEL |
| 20024498 | 20010412 | 1.67 | 90.4 | Adjuvant (A) | 2015-03-08 | 2015-03-12 | FEC + DOCETAXEL | 02 | Y | 20086566 | FEC + DOCETAXEL |
| 20024499 | 20010412 | 1.73 | 81 | Adjuvant (A) | 2015-01-06 | 2015-01-06 | FEC 100 + DOCETAXEL | 02 | N | 20086566 | FEC + DOCETAXEL |
| 20024500 | 20010413 | 1.55 | null | Neo-adjuvant (N) | null | 2015-01-14 | FEC 100 + DOCETAXEL | null | null | 20086575 | FEC + DOCETAXEL |
| 20024501 | 20071033 | 1.82 | 70.8 | Neo-adjuvant (N) | 2014-09-23 | 2014-09-30 | FEC 100 + DOCETAXEL | null | N | 20086576 | FEC + DOCETAXEL |
| 20024502 | 20071033 | 1.73 | 63.4 | Adjuvant (A) | 2014-11-15 | 2014-11-29 | FEC + DOCETAXEL | 2 | N | 20086576 | FEC + DOCETAXEL |
| 20024503 | 20071033 | null | 66.3 | Adjuvant (A) | null | 2015-09-03 | FEC + DOCETAXEL | null | null | 20086576 | FEC + DOCETAXEL |
| 20024504 | 20010414 | 1.67 | 91.9 | Adjuvant (A) | 2015-01-04 | 2015-01-23 | FEC + DOCETAXEL | 02 | N | 20086583 | FEC + DOCETAXEL |
| 20024505 | 20010414 | 1.71 | 68.7 | Neo-adjuvant (N) | 2014-12-13 | 2014-12-22 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 2 | N | 20086583 | FEC + DOCETAXEL |
| 20024506 | 20010414 | 1.55 | null | Adjuvant (A) | 2013-11-24 | 2013-12-18 | FEC + DOCETAXEL | N | N | 20086583 | FEC + DOCETAXEL |
| 20024507 | 20010415 | 1.59 | 64.6 | Adjuvant (A) | 2016-06-20 | 2016-07-06 | FEC + DOCETAXEL | N | N | 20086589 | FEC + DOCETAXEL |
| 20024508 | 20071035 | 1.54 | 60.8 | Adjuvant (A) | 2016-12-17 | 2016-12-30 | FEC 100 + DOCETAXEL | 02 | N | 20086592 | FEC + DOCETAXEL |
| 20024509 | 20071035 | null | 77.5 | Adjuvant (A) | 2013-09-03 | 2013-09-10 | FEC + DOCETAXEL | N | N | 20086592 | FEC + DOCETAXEL |